运动员不适当的窦性心动过速:营养药品能起作用吗?

IF 2.4 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Antonio Scarà, Alessio Borrelli, Antonio Gianluca Robles, Sara Burazor, Lorenzo-Lupo Dei, Federico Zanin, Leonardo Pignalosa, Elena Cavarretta, Liuba Fusco, Andrej Pernat, Valerio Sanguigni, Silvio Romano, Luigi Sciarra
{"title":"运动员不适当的窦性心动过速:营养药品能起作用吗?","authors":"Antonio Scarà, Alessio Borrelli, Antonio Gianluca Robles, Sara Burazor, Lorenzo-Lupo Dei, Federico Zanin, Leonardo Pignalosa, Elena Cavarretta, Liuba Fusco, Andrej Pernat, Valerio Sanguigni, Silvio Romano, Luigi Sciarra","doi":"10.3390/jcdd12020073","DOIUrl":null,"url":null,"abstract":"<p><p><i>Introduction:</i> Inappropriate sinus tachycardia (IST) is a syndrome characterized by unexpectedly fast and prolonged sinus rates at rest or with minimal physical activity. Epidemiologic characteristics are uncertain, but most patients are young and female. When IST occurs in athletes, its management (controlling symptoms and reducing heart rate) can present additional challenges. We designed an observational pilot study to investigate whether a food supplement can be useful in the treatment of IST when standard therapy is refused. <i>Methods:</i> We enrolled 50 consecutive recreational athletes affected by frequent recurrences of IST. Twelve-lead ECG and Holter ECG parameters were recorded at enrollment (T0) and after a 6-month treatment (T1) with the food supplement. Symptoms and quality of life were also evaluated through specific questionnaires. The study population was compared to a historical control group of 25 patients receiving ivabradine as treatment for the same clinical condition. <i>Results:</i> The resting ECG heart rate was 88.7 ± 12.4 bpm (T0) and 73.6 ± 6.6 bpm (T1) (<i>p</i> < 0.00001); Holter average heart rate was 88.4 ± 3.3 bpm and 74.9 ± 4.8 bpm (<i>p</i> < 0.0001). Holter ECG maximum heart rate was 147.1 ± 16.7 bpm and 139.2 ± 16.8 bpm (<i>p</i> = 0.06); Holter minimum heart rate was 49.9 ± 6.5 bpm and 50.5 ± 6.9 bpm (<i>p</i> = 0.33). Finally, the number of sustained episodes decreased from 3.3 ± 1.7 to 0.8 ± 0.8 (<i>p</i> < 0.00001). The following variations in ASTA scores were observed: ASTA symptom scale (range: 0-27) decreased from 14.9 ± 2.1 to 5.8 ± 1.4 (<i>p</i> < 0.00001), while ASTA HR QoL (range: 0-39) decreased from 24.1 ± 2.1 to 10.8 ± 2.3 (<i>p</i> < 0.00001). <i>Conclusions:</i> The findings of our pilot study suggest that this food supplement could play a beneficial role in managing symptoms and improving quality of life in recreational athletes affected by IST who refuse standard medical therapy. These clinical effects appear to correlate with significant improvements in resting ECG parameters and some Holter ECG parameters.</p>","PeriodicalId":15197,"journal":{"name":"Journal of Cardiovascular Development and Disease","volume":"12 2","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11856373/pdf/","citationCount":"0","resultStr":"{\"title\":\"Inappropriate Sinus Tachycardia in Athletes: Could Nutraceuticals Play a Role?\",\"authors\":\"Antonio Scarà, Alessio Borrelli, Antonio Gianluca Robles, Sara Burazor, Lorenzo-Lupo Dei, Federico Zanin, Leonardo Pignalosa, Elena Cavarretta, Liuba Fusco, Andrej Pernat, Valerio Sanguigni, Silvio Romano, Luigi Sciarra\",\"doi\":\"10.3390/jcdd12020073\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><i>Introduction:</i> Inappropriate sinus tachycardia (IST) is a syndrome characterized by unexpectedly fast and prolonged sinus rates at rest or with minimal physical activity. Epidemiologic characteristics are uncertain, but most patients are young and female. When IST occurs in athletes, its management (controlling symptoms and reducing heart rate) can present additional challenges. We designed an observational pilot study to investigate whether a food supplement can be useful in the treatment of IST when standard therapy is refused. <i>Methods:</i> We enrolled 50 consecutive recreational athletes affected by frequent recurrences of IST. Twelve-lead ECG and Holter ECG parameters were recorded at enrollment (T0) and after a 6-month treatment (T1) with the food supplement. Symptoms and quality of life were also evaluated through specific questionnaires. The study population was compared to a historical control group of 25 patients receiving ivabradine as treatment for the same clinical condition. <i>Results:</i> The resting ECG heart rate was 88.7 ± 12.4 bpm (T0) and 73.6 ± 6.6 bpm (T1) (<i>p</i> < 0.00001); Holter average heart rate was 88.4 ± 3.3 bpm and 74.9 ± 4.8 bpm (<i>p</i> < 0.0001). Holter ECG maximum heart rate was 147.1 ± 16.7 bpm and 139.2 ± 16.8 bpm (<i>p</i> = 0.06); Holter minimum heart rate was 49.9 ± 6.5 bpm and 50.5 ± 6.9 bpm (<i>p</i> = 0.33). Finally, the number of sustained episodes decreased from 3.3 ± 1.7 to 0.8 ± 0.8 (<i>p</i> < 0.00001). The following variations in ASTA scores were observed: ASTA symptom scale (range: 0-27) decreased from 14.9 ± 2.1 to 5.8 ± 1.4 (<i>p</i> < 0.00001), while ASTA HR QoL (range: 0-39) decreased from 24.1 ± 2.1 to 10.8 ± 2.3 (<i>p</i> < 0.00001). <i>Conclusions:</i> The findings of our pilot study suggest that this food supplement could play a beneficial role in managing symptoms and improving quality of life in recreational athletes affected by IST who refuse standard medical therapy. These clinical effects appear to correlate with significant improvements in resting ECG parameters and some Holter ECG parameters.</p>\",\"PeriodicalId\":15197,\"journal\":{\"name\":\"Journal of Cardiovascular Development and Disease\",\"volume\":\"12 2\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11856373/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiovascular Development and Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jcdd12020073\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Development and Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcdd12020073","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

不适当的窦性心动过速(IST)是一种综合征,其特征是在休息或很少的身体活动时意想不到的快速和延长的窦性心动过速。流行病学特征不确定,但大多数患者为年轻女性。当IST发生在运动员身上时,其管理(控制症状和降低心率)可能会带来额外的挑战。我们设计了一项观察性试点研究,以调查当拒绝标准治疗时,食物补充剂是否可以用于治疗IST。方法:我们连续招募了50名经常复发IST的休闲运动员。12导联心电图和动态心电图参数记录在入组时(T0)和用食物补充剂治疗6个月后(T1)。通过具体的问卷对症状和生活质量进行评估。研究人群与25名接受伊伐布雷定治疗相同临床状况的患者的历史对照组进行比较。结果:静息心电图心率分别为88.7±12.4 bpm (T0)和73.6±6.6 bpm (T1) (p < 0.00001);Holter平均心率分别为88.4±3.3 bpm和74.9±4.8 bpm (p < 0.0001)。动态心电图最大心率分别为147.1±16.7 bpm和139.2±16.8 bpm (p = 0.06);Holter最小心率分别为49.9±6.5 bpm和50.5±6.9 bpm (p = 0.33)。最后,持续发作次数从3.3±1.7次减少到0.8±0.8次(p < 0.00001)。ASTA评分的变化如下:ASTA症状量表(范围:0-27)从14.9±2.1降至5.8±1.4 (p < 0.00001), ASTA HR生活质量(范围:0-39)从24.1±2.1降至10.8±2.3 (p < 0.00001)。结论:我们的初步研究结果表明,这种食物补充剂可以在控制症状和改善生活质量方面发挥有益的作用,这些运动员受IST影响,拒绝标准的药物治疗。这些临床效果似乎与静息心电图参数和某些动态心电图参数的显著改善有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Inappropriate Sinus Tachycardia in Athletes: Could Nutraceuticals Play a Role?

Introduction: Inappropriate sinus tachycardia (IST) is a syndrome characterized by unexpectedly fast and prolonged sinus rates at rest or with minimal physical activity. Epidemiologic characteristics are uncertain, but most patients are young and female. When IST occurs in athletes, its management (controlling symptoms and reducing heart rate) can present additional challenges. We designed an observational pilot study to investigate whether a food supplement can be useful in the treatment of IST when standard therapy is refused. Methods: We enrolled 50 consecutive recreational athletes affected by frequent recurrences of IST. Twelve-lead ECG and Holter ECG parameters were recorded at enrollment (T0) and after a 6-month treatment (T1) with the food supplement. Symptoms and quality of life were also evaluated through specific questionnaires. The study population was compared to a historical control group of 25 patients receiving ivabradine as treatment for the same clinical condition. Results: The resting ECG heart rate was 88.7 ± 12.4 bpm (T0) and 73.6 ± 6.6 bpm (T1) (p < 0.00001); Holter average heart rate was 88.4 ± 3.3 bpm and 74.9 ± 4.8 bpm (p < 0.0001). Holter ECG maximum heart rate was 147.1 ± 16.7 bpm and 139.2 ± 16.8 bpm (p = 0.06); Holter minimum heart rate was 49.9 ± 6.5 bpm and 50.5 ± 6.9 bpm (p = 0.33). Finally, the number of sustained episodes decreased from 3.3 ± 1.7 to 0.8 ± 0.8 (p < 0.00001). The following variations in ASTA scores were observed: ASTA symptom scale (range: 0-27) decreased from 14.9 ± 2.1 to 5.8 ± 1.4 (p < 0.00001), while ASTA HR QoL (range: 0-39) decreased from 24.1 ± 2.1 to 10.8 ± 2.3 (p < 0.00001). Conclusions: The findings of our pilot study suggest that this food supplement could play a beneficial role in managing symptoms and improving quality of life in recreational athletes affected by IST who refuse standard medical therapy. These clinical effects appear to correlate with significant improvements in resting ECG parameters and some Holter ECG parameters.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Cardiovascular Development and Disease
Journal of Cardiovascular Development and Disease CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.60
自引率
12.50%
发文量
381
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信